Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 Barbara Alicja Jereczek-FossaMatteo Pepaon behalf of the CODRAL (Board of Directors of Radiation Oncology Departments in Lombardy) network and of AIRO-L (Italian Association of Radiotherapy and Clinical Oncology – Lombardy) Original Paper 04 November 2020 Article: 108
B7-1 and GM-CSF enhance the anti-tumor immune effect of DC-tumor fusion vaccine in the treatment of prostate cancer Tong LianXiaodong HaoChangying Li Original Paper 02 November 2020 Article: 107
Beyond bevacizumab: a review of targeted agents in metastatic small bowel adenocarcinoma Danielle Benedict SacdalanMarvin Jonne MendozaDennis L. Sacdalan Review Article 01 November 2020 Article: 106
Organoid culture system for patient-derived lung metastatic osteosarcoma Aina HeYujing HuangDongxi Xiang Original Paper 20 October 2020 Article: 105
Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis Zhuoling ZhengJingwen XieXiaoyan Li Original Paper 19 October 2020 Article: 104
The clinical significance of CD49e and CD56 for multiple myeloma in the novel agents era Miyuki OkuraNaoko IdaTakahiro Yamauchi Original Paper 17 October 2020 Article: 103
The investigation of the healing effect of active ingredients in traditional medicinal plants on lung cancer Faik Gökalp Original Paper 15 October 2020 Article: 102
Economic perspective of cancer treatment in India Aparna NatarajanNikita MehraThangarajan Rajkumar Short Communication 15 October 2020 Article: 101
Strategies for having a more effective and less toxic CAR T-cell therapy for acute lymphoblastic leukemia Mohadese Hashem BoroojerdiFatemeh RahbarizadehPooria Safarzadeh Kozani Review Article 12 October 2020 Article: 100
Synergistic effects of multiple myeloma cells and tumor-associated macrophages on vascular endothelial cells in vitro Miaomiao SunSen QiuKuisheng Chen Original Paper 10 October 2020 Article: 99
The prostate-specific membrane antigen (PSMA)-targeted radiotracer 18F-DCFPyL detects tumor neovasculature in metastatic, advanced, radioiodine-refractory, differentiated thyroid cancer Prasanna SanthanamJonathon RussellSteven P. Rowe Original Paper 09 October 2020 Article: 98
The DPP-IV inhibitor saxagliptin promotes the migration and invasion of papillary thyroid carcinoma cells via the NRF2/HO1 pathway Liang HeTing ZhangHao Zhang Original Paper 01 October 2020 Article: 97